Dr. John A. Osborne is the founder and director of State of the Heart Cardiology in Dallas, TX. He earned his BS from Penn State, his MD magna cum laude from Jefferson Medical College, and his PhD in cardiovascular physiology from Thomas Jefferson University. Dr. Osborne completed his post-doctoral training at Harvard Medical School and Brigham and Women’s Hospital, where he specialized in Internal Medicine and Cardiovascular Disease. He has published extensively on atherosclerosis and vascular biology. His clinical expertise spans preventive cardiology, cardiometabolic disease, hypertension, and cardiovascular genetics. Dr. Osborne is uniquely board-certified in Cardiology, Internal Medicine, Lipidology, Clinical Hypertension, Cardiac CT Angiography, Echocardiography, and Nuclear Cardiology.
While fibrates are proven to lower triglyceride levels, which can serve as a biomarker for cardiovascular disease risk, several major clinical studies from the past 20 years have failed to show a benefit of fenofibrates over and above statins in further reducing heart-related events.